Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this charting update.
Share Talk Bulletin Board Heroes, Thursday 5th September 2019
Tiziana Life Sci PLC (LON:TILS) Phase 2a Clinical Data
Tiziana Life Sciences Reports Positive Phase 2a Clinical Data Exhibiting Positive Clinical Activity with Milciclib Monotherapy in Advanced Sorafenib-refractory or -intolerant Patients with Unresectable or Metastatic Hepatocellular Carcinoma
Share Talk Weekly Stock Market News, 27th July 2019
Share Talk was back in London this week on business and we held a few meeting with listed companies, some of the market sectors are currently struggling in the small-cap
Tiziana Life Sci PLC (NASDAQ:TLSA LON:TILS) Dr Kunwar Shailubhai, CEO & CSO
Tiziana Reports Phase 2a Clinical Data with Milciclib Monotherapy in Sorafenib-refractory or -intolerant patients with unresectable or metastatic Hepatocellular Carcinoma.
Share Talk Weekly Stock Market News, 30th June 2019
Another hectic week in the markets with lots of updates posted on the Share Talk website.
Kunwar Shailubhai, CEO of Tiziana Life Sciences (NASDAQ:TLSA, AIM:TILS) Interview
Zak Mir speaks with Kunwar Shailubhai, CEO of Tiziana Life Sciences, are the markets, prospective investor understanding the business model?. As is often the case the focus is on a company
Share Talk Bulletin Board Heroes: 27th Sep 2018
A charting look at some of the most followed stocks on the London market, Zak Mir covers.
Tiziana Life Sciences (AIM:TILS) Phase II Clinical Trial Update
Tiziana Life Sciences plc (AIM: TILS), a clinical stage biotechnology company developing targeted drugs for cancer and inflammatory diseases, today announces that milciclib, a small molecular pan-inhibitor of cyclin dependent
and then 